top of page
What Is Spravato?
Spravato (esketamine) is an FDA-approved nasal spray for adults with treatment-resistant depression, used with an oral antidepressant. At CanaryCare, we provide this innovative therapy within a safe, controlled clinical environment to ensure patient well-being.
Comfortable, Private, and Clinically Supervised
Our private treatment room is designed to help patients feel comfortable throughout their monitored visit.
What to Expect During Treatment
1
Clinical screening and insurance verification
2
Arrival and pre-treatment assessment
3
Self-administration under clinical supervision
4
Required monitoring before discharge
Safety Considerations
Patients need transportation home after treatment and should follow all individualized safety instructions provided by their clinician.
Insurance and Authorization
Coverage and authorization requirements vary by plan. CanaryCare can help verify benefits before treatment begins.
​
Informational purposes only. Not medical advice.
bottom of page